ArticlePediatric cardiology2026
Parallel Transcatheter Valve and Stent Placement with Subsequent Stent Occlusion to Address a Giant Dysfunctional RVOT in a Patient with Repaired Tetralogy of Fallot.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tetralogy of Fallot (TOF) is a common cyanotic congenital heart defect whose surgical repair has improved long-term survival. However, many patients develop right ventricular outflow tract (RVOT) dysfunction and severe pulmonary insufficiency (PI), often leading to right ventricular dilatation and arrhythmias. Pulmonary valve replacement (PVR) is the standard treatment. Open surgery remains the preferred option in many cases, especially when the RVOT is large or has a complex anatomy. However, in patients with significant comorbidities that increase surgical risk, percutaneous options may be a viable alternative. In the case we present, an innovative approach was used, as the patient was not a candidate for surgery due to his high comorbidity (bladder neoplasm, obesity and severe obstructive respiratory pattern) and his giant RVOT posed a challenge for percutaneous valve options. A large Myval
Indexed as
Identifiers
41269258What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.